Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.

Current State and Utility of Biomarkers in Acute Respiratory Distress Syndrome

May 17, 2018 (Noon - 1:30 p.m. ET)

Sponsor/Co-Sponsor(s)

Obstetric and Pediatric Pharmacology and Therapeutics Branch (OPPTB), Best Pharmaceuticals for Children Act (BPCA), NICHD

Location

6700A Rockledge Drive, Bethesda, MD

Purpose

Anil Sapru, M.D. and Michael A. Matthay, M.D., will review biomarker studies for acute respiratory distress syndrome in children and adults. They will also the discuss the possible use of biological markers to improve the design of clinical trials.

Dr. Sapru is a professor of pediatrics and the division chief of critical care at the UCLA Mattel Children's Hospital. Dr. Matthay is a professor of medicine and anesthesia at the University of California at San Francisco. He also is a senior associate at the Cardiovascular Research Institute.

Contact

George Giacoia, OPPTB, NICHD
Phone: (301) 496-5589
E-mail: giacoiag@mail.nih.gov

Please note: Views expressed during NICHD-sponsored events do not necessarily reflect the opinions or the official positions of NICHD, NIH, or HHS.